Text Size

Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:
NCT00407108
First received: June 30, 2006
Last updated: December 5, 2006
Last verified: November 2006
History of Changes
  Purpose

To investigate the feasibility and advantages of using perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting vitrectomy using a dual, dynamic drive (3D)technology. In complicated surgeries in advanced diabetic retinopathy and retinal detachment


Condition Intervention Phase
Diabetic Retinopathy
 Procedure: Vitrectomy
 Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Asociación para Evitar la Ceguera en México:

Primary Outcome Measures:
  • Surgical time
  • Facility of surgical maneuvers

Study Start Date: March 2006
Estimated Study Completion Date: June 2006
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Advanced diabetic retinopathy with retinal detachment

Exclusion Criteria:

  • Retinal detachments of more than 6 months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00407108

Contacts
Contact: Hugo Quiroz-Mercado, MD 5255 10841400 ext 1171 retinamex@yahoo.com

Locations
Mexico
Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes" Recruiting
Mexico City, Mexico DF, Mexico, 04030
Contact: Maria A Martínez-Cstellanos, MD     52 55 10841400 ext 1171     retinamex@yahoo.com    
Principal Investigator: Hugo Quiroz-Mercado, MD            
Sub-Investigator: María A Martinez-Castellanos, MD            
Sub-Investigator: Gerardo García-Aguirre, MD            
Sub-Investigator: Orlando Ustariz-González, MD            
Sub-Investigator: Jose L Guerrero-Naranjo, MD            
Sub-Investigator: Jans Fromow-Guerra, MD            
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Hugo Quiroz-Mercado, MD Asociación para Evitar la Ceguera en México
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00407108     History of Changes
Other Study ID Numbers: APEC-005
Study First Received: June 30, 2006
Last Updated: December 5, 2006
Health Authority: Mexico: Secretaria de Salud

Keywords provided by Asociación para Evitar la Ceguera en México:
vitreoretinal surgery

Additional relevant MeSH terms:
Diabetic Retinopathy
Retinal Diseases
Eye Diseases
Diabetic Angiopathies
Vascular Diseases
 Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 22, 2013